September 12, 2019
The Federal Trade Commission on Tuesday announced that it has warned three companies for advertising that their cannabidiol products can treat medical conditions without evidence to support those claims.
September 9, 2019
Public health officials on Friday reported more deaths likely caused by a lung illness tied to e-cigarette use and vaping, as federal health agencies issued conflicting warnings about vaping and e-cigarette use.
While medication-assisted treatment is considered "the gold standard" for managing opioid-related substance use disorders, most state programs for health care professionals seeking to recover from opioid use disorders often deny access to such medications.
September 6, 2019
Federal and state health officials this week announced they have identified high levels of vitamin E acetate in samples of marijuana vaping products that have been linked to a deadly lung illness affecting patients across the United States.
Sean Blake died of a drug-related overdose in August 2017, after nearly a decade cycling in and out of substance use disorder (SUD) treatment programs that cost his family $110,000—a story that highlights the flaws in the U.S. SUD treatment system.
HHS on Wednesday announced it will award more than $1.8 billion in funding to help states and communities continue to combat the opioid epidemic and improve data collection to track progress.
American Health Line rounds up the latest health care news in the states.
September 4, 2019
CDC and FDA on Friday warned e-cigarette users against using vaping ingredients purchased from unauthorized vendors and modifying vaping products, citing an increase in cases of a mysterious lung illness tied to e-cigarette use and vaping.
September 3, 2019
U.S. Surgeon General Jerome Adams on Thursday issued an advisory warning pregnant women and youth against using marijuana, saying the substance can pose risks to developing brains.
August 28, 2019
The Drug Enforcement Administration on Monday announced that it will move forward with a years-delayed expansion of the agency's marijuana research program, meaning the agency soon could permit more growers to produce marijuana for use in medical studies and other research.
Advisory Board. All rights reserved.